Skip to main content
GR

Graph Therapeutics

Vienna, Austria
Last funding
$5.0M
SeedJun 2026

precision-immunology techbio

Backed byDaphniMerantix CapitalSquareOne Venture CapitalMehdi Ghissassiaustria Wirtschaftsservice (aws)

About Graph Therapeutics

How much funding has Graph Therapeutics raised?

Graph Therapeutics has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in June 2026.

Who are Graph Therapeutics's investors?

Graph Therapeutics's investors include Daphni, Merantix Capital, SquareOne Venture Capital, Mehdi Ghissassi, austria Wirtschaftsservice (aws).

Where is Graph Therapeutics headquartered?

Graph Therapeutics is headquartered in Vienna, Austria.

What does Graph Therapeutics do?

precision-immunology techbio

What stage is Graph Therapeutics at?

Graph Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Graph Therapeutics — Funding & Investors." VCBacked, June 22, 2026, https://www.vcbacked.co/company/graph-therapeutics. Accessed November 15, 2026.
APA
VCBacked. (2026). Graph Therapeutics — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/graph-therapeutics
Wikipedia (cite web)
{{cite web |title=Graph Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/graph-therapeutics |website=VCBacked |access-date=November 15, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Graph Therapeutics? Request a listing update

Founder contacts
m***@graphtx.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →